PUK7 THE PHARMACY BUDGET IMPACT OF EXTENDING REIMBURSEMENT OF LANTHANUM CARBONATE TO TREATMENT OF HYPERPHOSPHATEMIA (1.78 MMOL/L) IN PATIENTS WITH CHRONIC KIDNEY DISEASE PRE-DIALYSIS IN FRANCE AND THE UNITED KINGDOM
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)73023-6
https://www.valueinhealthjournal.com/article/S1098-3015(11)73023-6/fulltext
Title :
PUK7 THE PHARMACY BUDGET IMPACT OF EXTENDING REIMBURSEMENT OF LANTHANUM CARBONATE TO TREATMENT OF HYPERPHOSPHATEMIA (1.78 MMOL/L) IN PATIENTS WITH CHRONIC KIDNEY DISEASE PRE-DIALYSIS IN FRANCE AND THE UNITED KINGDOM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73023-6&doi=10.1016/S1098-3015(11)73023-6
First page :
A474
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
1182